| For: | Pabla B, Bissonnette M, Konda VJ. Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention. World J Clin Oncol 2015; 6(5): 133-141 [PMID: 26468449 DOI: 10.5306/wjco.v6.i5.133] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v6/i5/133.htm |
| Number | Citing Articles |
| 1 |
Adewale Oluwaseun Fadaka, Olalekan Olanrewaju Bakare, Ashley Pretorius, Ashwil Klein. Genomic profiling of microRNA target genes in colorectal cancer. Tumor Biology 2020; 42(6) doi: 10.1177/1010428320933512
|
| 2 |
Akanksha Patel, Mattia Tiboni, Luca Casettari, Ketan Patel. Microfluidic-assisted preparation of ARV 825 and Osimertinib loaded liposomal formulation as a potential system for colorectal cancer therapy. International Journal of Pharmaceutics 2025; 686 doi: 10.1016/j.ijpharm.2025.126358
|
| 3 |
Peyton High, Cara Guernsey, Shraddha Subramanian, Joan Jacob, Kendra S. Carmon. The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases. Pharmaceutics 2024; 16(7) doi: 10.3390/pharmaceutics16070890
|
| 4 |
Mohammed Salah Ayoup, Islam Shawki, Hamida Abdel-Hamid, Doaa A. Ghareeb, Aliaa Masoud, Marwa F. Harras, Mohamed El-Atawy, Nuha Salamah Alharbi, Magda M. F. Ismail. Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles. RSC Advances 2024; 14(24) doi: 10.1039/D4RA02222J
|
| 5 |
Maha-Hamadien Abdulla, Shaik Sultana, Mansoor-Ali Vaali‑Mohammed, Khayal Al Khayal, Thamer Traiki, Ahmad Zubaidi, Tariq Al‑Johani, Zahid Shakoor, Omar Abdullah‑Al Obeed. Expression of VEGF, EGF and HGF in early‑ and late‑stage colorectal cancer. Molecular and Clinical Oncology 2021; 15(6) doi: 10.3892/mco.2021.2413
|
| 6 |
Chunfeng Wang, Na Wang, Na Li, Qiuying Yu, Fangyu Wang. Combined Effects of Resveratrol and Vitamin E From Peanut Seeds and Sprouts on Colorectal Cancer Cells. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.760919
|
| 7 |
Gavin W. Roddy. Metabolic syndrome and the aging retina. Current Opinion in Ophthalmology 2021; 32(3) doi: 10.1097/ICU.0000000000000747
|
| 8 |
Ji Hye Shin, Mi-Jeong Kim, Ji Young Kim, Bongkum Choi, Yeeun Kang, Seo Hyun Kim, Ha-Jeong Lee, Dohee Kwon, Yong Beom Cho, Kyeong Kyu Kim, Eunyoung Chun, Ki-Young Lee. USP21-EGFR signaling axis is functionally implicated in metastatic colorectal cancer. Cell Death Discovery 2024; 10(1) doi: 10.1038/s41420-024-02255-1
|
| 9 |
Said Bitam, Mabrouk Hamadache, Salah Hanini. Discovery of novel natural product-derived EGFR inhibitors using multiple linear regression, stacked ensemble regression, and fingerprinting approaches. Journal of Computer-Aided Molecular Design 2026; 40(1) doi: 10.1007/s10822-025-00731-z
|
| 10 |
Jian Wang, Wei Li, Bo Wang, Baichun Hu, Hailun Jiang, Bate Lai, Ning Li, Maosheng Cheng. In Silicon Approach for Discovery of Chemopreventive Agents. Current Pharmacology Reports 2017; 3(4) doi: 10.1007/s40495-017-0094-1
|
| 11 |
MM Atef, AI Amer, YM Hafez, MA Elsebaey, SA Saber, SR Abd El-Khalik. Long non-coding RNA EGFR-AS1 in colorectal cancer: potential role in tumorigenesis and survival via miRNA-133b sponge and EGFR/STAT3 axis regulation. British Journal of Biomedical Science 2021; 78(3) doi: 10.1080/09674845.2020.1853913
|
| 12 |
Uriel Bachrach, Zohara Yaniv. Medicinal Plants - Recent Advances in Research and Development. 2016; doi: 10.1007/978-981-10-1085-9_13
|
| 13 |
Ya-di Duan, Yan-yan Jiang, Feng-xia Guo, Lu-xiao Chen, Lu-lu Xu, Wei Zhang, Bin Liu. The antitumor activity of naturally occurring chromones: A review. Fitoterapia 2019; 135 doi: 10.1016/j.fitote.2019.04.012
|
| 14 |
Sarmila Loganathan, Najihah Mohd Hashim, Wan Izlina Wan Ibrahim, Nurshamimi Nor Rashid. Unlocking the anticancer potential of Morinda citrifolia-derived anthraquinones: Preclinical evidence and molecular mechanisms in colorectal cancer. Pharmacological Research - Natural Products 2025; 9 doi: 10.1016/j.prenap.2025.100414
|
| 15 |
Dipa K. Israni, Jignesh Shah, Mansi Shah, Heena Chauhan, Bhupendra G. Prajapati, Yunqi Zhao, Chuda Chittasupho, Sudarshan Singh. Emerging Molecular Insights and Targeted Therapeutics in Colorectal Cancer: From Emerging Approaches to Personalized Medicine. Journal of Gastrointestinal Cancer 2026; 57(1) doi: 10.1007/s12029-026-01447-5
|
| 16 |
Asma Ahmed, Christian Schmidt, Thomas Brunner. Extra-Adrenal Glucocorticoid Synthesis in the Intestinal Mucosa: Between Immune Homeostasis and Immune Escape. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01438
|
| 17 |
Rui Dai, Wei Chen, You Chen, Jinlong Jin, Shiwei Zhang, Changhua Zhang, Jie Liu. 3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation. Biofabrication 2024; 16(3) doi: 10.1088/1758-5090/ad51a6
|
| 18 |
Martina Lepore Signorile, Valentina Grossi, Candida Fasano, Cristiano Simone. Colorectal Cancer Chemoprevention: A Dream Coming True?. International Journal of Molecular Sciences 2023; 24(8) doi: 10.3390/ijms24087597
|
| 19 |
Mohamed E. M. Saeed, Rümeysa Yücer, Mona Dawood, Mohamed-Elamir F. Hegazy, Assia Drif, Edna Ooko, Onat Kadioglu, Ean-Jeong Seo, Fadhil S. Kamounah, Salam J. Titinchi, Beatrice Bachmeier, Thomas Efferth. In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors. International Journal of Molecular Sciences 2022; 23(7) doi: 10.3390/ijms23073966
|
| 20 |
Sadia Afrin, Francesca Giampieri, Massimiliano Gasparrini, Tamara Forbes-Hernandez, Alfonso Varela-López, José Quiles, Bruno Mezzetti, Maurizio Battino. Chemopreventive and Therapeutic Effects of Edible Berries: A Focus on Colon Cancer Prevention and Treatment. Molecules 2016; 21(2) doi: 10.3390/molecules21020169
|
| 21 |
Nur V. Bihud, Nurulfazlina E. Rasol, Syahrul Imran, Khalijah Awang, Fasihuddin B. Ahmad, Chun-Wai Mai, Chee-Onn Leong, Geoffrey A. Cordell, Nor Hadiani Ismail. Goniolanceolatins A–H, Cytotoxic Bis-styryllactones from Goniothalamus lanceolatus. Journal of Natural Products 2019; 82(9) doi: 10.1021/acs.jnatprod.8b01067
|
| 22 |
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Abdulqahar Azizkhan Mohammed, Mohammed Fatih Rasul, Ali M. Hussein, Solat Eslami, Mark C. Glassy, Mohammad Taheri. Advanced strategies of targeting circular RNAs as therapeutic approaches in colorectal cancer drug resistance. Pathology - Research and Practice 2024; 260 doi: 10.1016/j.prp.2024.155402
|
| 23 |
Anuraj Nayarisseri, Sanjeev Kumar Singh. Functional Inhibition of VEGF and EGFR Suppressors in Cancer Treatment. Current Topics in Medicinal Chemistry 2019; 19(3) doi: 10.2174/156802661903190328155731
|
| 24 |
Nabarun Roy, P. A. Nazeem, T. D. Babu, P. S. Abida, Arunaksharan Narayanankutty, Ravisankar Valsalan, P. A. Valsala, Achuthan C. Raghavamenon. EGFR gene regulation in colorectal cancer cells by garlic phytocompounds with special emphasis on S-Allyl-L-Cysteine Sulfoxide. Interdisciplinary Sciences: Computational Life Sciences 2018; 10(4) doi: 10.1007/s12539-017-0227-6
|
| 25 |
Bernhard Blank-Landeshammer, Vincent R. Richard, Georgia Mitsa, Maud Marques, André LeBlanc, Laxmikanth Kollipara, Ingo Feldmann, Mathilde Couetoux du Tertre, Karen Gambaro, Suzan McNamara, Alan Spatz, René P. Zahedi, Albert Sickmann, Gerald Batist, Christoph H. Borchers. Proteogenomics of Colorectal Cancer Liver Metastases: Complementing Precision Oncology with Phenotypic Data. Cancers 2019; 11(12) doi: 10.3390/cancers11121907
|
| 26 |
Sun-Ji Park, Sung-Woo Lee, Heegyum Moon, Su-Min Jung, Jin-Man Kim, Dong-Seok Lee, Eui-Hwan Choi. Amphiregulin drives EGFR-dependent genome stability in colorectal cancer and represents a targetable vulnerability. Oncogene 2026; doi: 10.1038/s41388-026-03850-5
|
| 27 |
Guillermo Tirado-Rodríguez, Inmaculada Ruiz-Montesinos, Sira Iturrizaga, Amador García Ruiz de Gordejuela, Paula Aizpiolea, Daniel Alonso-Alconada, Ignacio García-Alonso, Borja Herrero de la Parte. Impact of neoadjuvant cetuximab on liver function and tumor reduction in a murine model of selective portal vein ligation. Clinical & Experimental Metastasis 2025; 43(1) doi: 10.1007/s10585-025-10386-7
|
| 28 |
|
| 29 |
Jinlong Li, Zhaoli Zhang, Lixue Wang, Yongchen Zhang. The oncogenic role of Wnt10a in colorectal cancer through activation of canonical Wnt/β‑catenin signaling. Oncology Letters 2019; doi: 10.3892/ol.2019.10035
|
| 30 |
Evangelos Koustas, Michalis V. Karamouzis, Chrysovalantou Mihailidou, Dimitrios Schizas, Athanasios G. Papavassiliou. Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer. Cancer Letters 2017; 396 doi: 10.1016/j.canlet.2017.03.023
|
| 31 |
Nidhi Mishra, Samipta Singh, Priyanka Maurya, Raquibun Nisha, Shubhini A. Saraf. Nanoformulations in Human Health. 2020; doi: 10.1007/978-3-030-41858-8_7
|
| 32 |
Simona Pellecchia, Gaetano Viscido, Melania Franchini, Gennaro Gambardella. Predicting drug response from single-cell expression profiles of tumours. BMC Medicine 2023; 21(1) doi: 10.1186/s12916-023-03182-1
|
| 33 |
Amrutha Krishnan K., Sudha George Valavi, Amitha Joy. Identification of Novel EGFR Inhibitors for the Targeted Therapy of Colorectal
Cancer Using Pharmacophore Modelling, Docking, Molecular Dynamic Simulation
and Biological Activity Prediction. Anti-Cancer Agents in Medicinal Chemistry 2024; 24(4) doi: 10.2174/0118715206275566231206094645
|
| 34 |
Alicja Pakiet, Jarosław Kobiela, Piotr Stepnowski, Tomasz Sledzinski, Adriana Mika. Changes in lipids composition and metabolism in colorectal cancer: a review. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-0977-8
|
| 35 |
William H Gmeiner. Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development. OncoTargets and Therapy 2021; doi: 10.2147/OTT.S242224
|
| 36 |
Hakeemah H. Al-nakhle. Unraveling the Multifaceted Role of the miR-17-92 Cluster in Colorectal Cancer: From Mechanisms to Biomarker Potential. Current Issues in Molecular Biology 2024; 46(3) doi: 10.3390/cimb46030120
|
| 37 |
Igor Moura de Paiva, Mohammad Reza Vakili, Amir Hasan Soleimani, Seyed Amirhossein Tabatabaei Dakhili, Sirazum Munira, Marco Paladino, Gary Martin, Frank R. Jirik, Dennis G. Hall, Michael Weinfeld, Afsaneh Lavasanifar. Biodistribution and Activity of EGFR Targeted Polymeric Micelles Delivering a New Inhibitor of DNA Repair to Orthotopic Colorectal Cancer Xenografts with Metastasis. Molecular Pharmaceutics 2022; 19(6) doi: 10.1021/acs.molpharmaceut.1c00918
|
| 38 |
Navina Panneerselvan, Rajeswari Ravindran, Palanisamy Arulselvan, Ravindran Jaganathan. Anticancer Plants: Mechanisms and Molecular Interactions. 2018; doi: 10.1007/978-981-10-8417-1_3
|
| 39 |
Simona Gabriela Duta-Ion, Ioana Ruxandra Juganaru, Iulian Andrei Hotinceanu, Andra Dan, Livia Malina Burtavel, Madalin Codrut Coman, Ina Ofelia Focsa, Andra Giorgiana Zaruha, Patricia Christina Codreanu, Laurentiu Camil Bohiltea, Viorica Elena Radoi. Redefining Therapeutic Approaches in Colorectal Cancer: Targeting Molecular Pathways and Overcoming Resistance. International Journal of Molecular Sciences 2024; 25(23) doi: 10.3390/ijms252312507
|
| 40 |
Katherine Weh, Jennifer Clarke, Laura Kresty. Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents. Antioxidants 2016; 5(3) doi: 10.3390/antiox5030027
|
| 41 |
Valentina Tullio, Valeria Gasperi, Maria Valeria Catani, Isabella Savini. The Impact of Whole Grain Intake on Gastrointestinal Tumors: A Focus on Colorectal, Gastric, and Esophageal Cancers. Nutrients 2020; 13(1) doi: 10.3390/nu13010081
|
| 42 |
Mohammed Salah Ayoup, Mariam Ghanem, Hamida Abdel-Hamid, Ibrahim Elghamry, Marwa M. Abu-Serie, Aliaa A. Masoud, Doaa A. Ghareeb, Marwa F. Harras, Magda M. F. Ismail, Amr Negm. Investigating the Anticancer Activity of Novel 1,2,4-Oxadiazole-Linked 1,2,3-Triazole Moieties via EGFR/pI3K/mTOR Cascade Down-Regulation. Polycyclic Aromatic Compounds 2025; 45(8) doi: 10.1080/10406638.2025.2476071
|
| 43 |
Sami El Khatib, Mohamed Salla. The mosaic puzzle of the therapeutic monoclonal antibodies and antibody fragments - A modular transition from full-length immunoglobulins to antibody mimetics. Leukemia Research Reports 2022; 18 doi: 10.1016/j.lrr.2022.100335
|
| 44 |
Vitor Jodar Cavalheiro, Daniel Santos Rocha Sobral Filho, Giulia Mazaro de Oliveira, Manuela del Rio Navarrete da Fonseca, Gabriel Travessini, Ibere Cauduro Soares, Gilberto de Castro Junior, Jorge Sabbaga, Milena Perez Mak, Paulo Marcelo Gehm Hoff. Metastatic colorectal adenocarcinoma with APC and EGFR L858R co-mutations: a case report. The Oncologist 2026; 31(3) doi: 10.1093/oncolo/oyaf421
|
| 45 |
Alice E. Shin, Filippo G. Giancotti, Anil K. Rustgi. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends in Pharmacological Sciences 2023; 44(4) doi: 10.1016/j.tips.2023.01.003
|
| 46 |
Claiborne W. Tydings, Bhuminder Singh, Adam W. Smith, Kaitlyn V. Ledwitch, Benjamin P. Brown, Christine M. Lovly, Allison S. Walker, Jens Meiler. Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics. Protein Science 2024; 33(10) doi: 10.1002/pro.5141
|
| 47 |
Kenneth K.W. To, Mingxia Wu, Christy W.S. Tong, Wei Yan. Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies. 2020; doi: 10.1016/B978-0-12-819937-4.00002-9
|
| 48 |
Irina V. Kholodenko, Aleena A. Saidova, Daria M. Potashnikova, Viktoriia A. Arzumanian, Daniil D. Romashin, Anna V. Tvorogova, Ekaterina V. Poverennaya, Konstantin N. Yarygin, Yan S. Kim. Contrasting Impacts of Targeted Disruption of the Cancer Stem Cell Marker CD133 and Its Epigenetic Regulator TRIM28 in Colorectal Cancer Cells. International Journal of Molecular Sciences 2025; 26(22) doi: 10.3390/ijms262210862
|
| 49 |
Fenglei Wang, Tomotaka Ugai, Koichiro Haruki, Yi Wan, Naohiko Akimoto, Kota Arima, Rong Zhong, Tyler S. Twombly, Kana Wu, Kanhua Yin, Andrew T. Chan, Marios Giannakis, Jonathan A. Nowak, Jeffrey A. Meyerhardt, Liming Liang, Mingyang Song, Stephanie A. Smith‐Warner, Xuehong Zhang, Edward L. Giovannucci, Walter C. Willett, Shuji Ogino. Healthy and unhealthy plant‐based diets in relation to the incidence of colorectal cancer overall and by molecular subtypes. Clinical and Translational Medicine 2022; 12(8) doi: 10.1002/ctm2.893
|
| 50 |
Zhongjie Xu, Lirong Zhang. BRCA1 expression serves a role in vincristine resistance in colon cancer cells. Oncology Letters 2017; 14(1) doi: 10.3892/ol.2017.6149
|
| 51 |
|
| 52 |
Mohammad Kashif. Gene expression profiling to uncover prognostic and therapeutic targets in colon cancer, combined with docking and dynamics studies to discover potent anticancer inhibitor. Computational Biology and Chemistry 2025; 115 doi: 10.1016/j.compbiolchem.2025.108349
|
| 53 |
Balakarthikeyan Janani, Mayakrishnan Vijayakumar, Kannappan Priya, Jin Hee Kim, D. S. Prabakaran, Mohammad Shahid, Sameer Al-Ghamdi, Mohammed Alsaidan, Nasraddin Othman Bahakim, Mohammad Hassan Abdelzaher, Thiyagarajan Ramesh. EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges. Vaccines 2022; 10(4) doi: 10.3390/vaccines10040499
|
| 54 |
J.H. Suh, A.M. Makarova, J.M. Gomez, L.A. Paul, J.D. Saba. An LC/MS/MS method for quantitation of chemopreventive sphingadienes in food products and biological samples. Journal of Chromatography B 2017; doi: 10.1016/j.jchromb.2017.07.040
|
| 55 |
Sara Y. Ewieda, Eman M. Ahmed, Peter A. Halim, Shaymaa G. Ibrahim, Khaled M. Gouda, Mohnad Abdalla, Wafa Ali Eltayb, Mohamed T.M. Nemr. Discovery of novel pyridazinone derivatives as EGFRWT/ EGFRT790M kinase inhibitors; design, synthesis, antitumor evaluation, and molecular dynamic simulations. Bioorganic Chemistry 2026; 170 doi: 10.1016/j.bioorg.2026.109486
|
| 56 |
John C. Marston, Gregory D. Kennedy, Suzanne E. Lapi, Yolanda E. Hartman, Morgan T. Richardson, Himani M. Modi, Jason M. Warram. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer. Journal of Surgical Research 2019; 239 doi: 10.1016/j.jss.2019.01.065
|
| 57 |
Vaishali Gupta, Taha Bharmal, Vineeta Dixit, Naveen Kumar Vishvakarma, Atul Kumar Tiwari, Dhananjay Shukla, Shirish Shukla. Colon Cancer Diagnosis and Therapy. 2021; doi: 10.1007/978-3-030-63369-1_11
|
| 58 |
Sayoni Nag, Krishna Das Saha. Chitosan-Decorated PLGA-NPs Loaded with Tannic Acid/Vitamin E Mitigate Colon Cancer via the NF-κB/β-Cat/EMT Pathway. ACS Omega 2021; 6(43) doi: 10.1021/acsomega.1c03477
|
| 59 |
Raquel B. Liszbinski, Graziela G. Romagnoli, Carolina M. Gorgulho, Caroline R. Basso, Valber A. Pedrosa, Ramon Kaneno. Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells. Materials 2020; 13(2) doi: 10.3390/ma13020375
|
| 60 |
Zijun Geng, Meiqi Chen, Qixuan Yu, Shuoxi Guo, Tianli Chen, Da Liu. Histone Modification of Colorectal Cancer by Natural Products. Pharmaceuticals 2023; 16(8) doi: 10.3390/ph16081095
|
| 61 |
Saimila Momin, Ganji Purnachandra Nagaraju. Role of Tyrosine Kinases in Gastrointestinal Malignancies. 2018; doi: 10.1007/978-981-13-1486-5_12
|
| 62 |
Yufei Liang, Guoqi Zheng, Wenjie Yin, Hui Song, Chunying Li, Liang Tian, Dongliang Yang. Significance of EGFR and PTEN Expression and PLR and NLR for Predicting the Prognosis of Epithelioid Malignant Peritoneal Mesothelioma. Gastroenterology Research and Practice 2019; 2019 doi: 10.1155/2019/7103915
|
| 63 |
Sicheng Yan, Fuyuan Zhan, Yuxuan He, Yuehong Zhu, Zhihong Ma. p53 in colorectal cancer: from a master player to a privileged therapy target. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-06566-4
|
| 64 |
Yumei Zhou, Xianfeng Chen, Jun Chen, Conner D. Kendrick, Ramesh K. Ramanathan, Rondell P. Graham, Kimberlee F. Kossick, Lisa A. Boardman, Michael T. Barrett. Genomic landscape of diploid and aneuploid microsatellite stable early onset colorectal cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59398-5
|
| 65 |
Marwa Elsbaey, Yasuhiro Igarashi, Radwan Alnajjar, Khaled M. Darwish, Tomofumi Miyamoto. Nuciferol C, a new sesquineolignan dimer from Cocos nucifera L.: bioactivity and theoretical investigation. RSC Advances 2024; 14(36) doi: 10.1039/D4RA02940B
|
| 66 |
Elena Daveri, Ana M. Adamo, Eugenia Alfine, Wei Zhu, Patricia I. Oteiza. Hexameric procyanidins inhibit colorectal cancer cell growth through both redox and non-redox regulation of the epidermal growth factor signaling pathway. Redox Biology 2021; 38 doi: 10.1016/j.redox.2020.101830
|
| 67 |
Mahasen M. Fouad, Hazem A. Ghabbour, Ihsan A. Shehata, Mahmoud B. El-Ashmawy. Synthesis and in vitro antitumor evaluation of new thieno[2,3-d]pyrimidine derivatives as EGFR and DHFR inhibitors. Bioorganic Chemistry 2024; 148 doi: 10.1016/j.bioorg.2024.107401
|
| 68 |
Derya Okuyan. Epidermal Growth Factor Downregulates Carbon Anhydrase III (CAIII) in Colon Cancer. Current Issues in Molecular Biology 2024; 46(11) doi: 10.3390/cimb46110774
|
| 69 |
Adewale Oluwaseun Fadaka, Ashwil Klein, Ashley Pretorius. In silico identification of microRNAs as candidate colorectal cancer biomarkers. Tumor Biology 2019; 41(11) doi: 10.1177/1010428319883721
|
| 70 |
Oluwatoyin Folake Olukunle, Victor Omoboyede, Prosper Obed Chukwuemeka.
Network pharmacology and molecular docking-based identification of drug candidates and key targets of
Allium sativum
for colorectal cancer treatment
. Journal of Biomolecular Structure and Dynamics 2024; 42(9) doi: 10.1080/07391102.2023.2220823
|
| 71 |
Jianan Xu, Lin Tian, Wenlong Qi, Qingguo Lv, Tan Wang. Advancements in NSCLC. American Journal of Clinical Oncology 2024; 47(6) doi: 10.1097/COC.0000000000001088
|
| 72 |
Awfa Y. Alazzeh, Firas S. Azzeh. Active lifestyle patterns reduce the risk of colorectal cancer in the Mecca region, Saudi Arabia: a case–control study. European Journal of Cancer Prevention 2018; 27(5) doi: 10.1097/CEJ.0000000000000361
|
| 73 |
Vedhapriya Souresh, M. Srikayalsamyukktha, M. Harini, Yudhesh Saravanan, Rupachandra Saravanakumar. Unlocking the Therapeutic Potential of Cyclic Peptide-Based Nanocarriers for Enhanced Colon Cancer Treatment. The Protein Journal 2025; 44(6) doi: 10.1007/s10930-025-10289-2
|
| 74 |
Soumya Narayana, B.H. Jaswanth Gowda, Umme Hani, Sharmin Sultana Shimu, Karthika Paul, Avinaba Das, Sumel Ashique, Mohammed Gulzar Ahmed, Maryam Abbasi Tarighat, Gholamreza Abdi. Inorganic nanoparticle-based treatment approaches for colorectal cancer: recent advancements and challenges. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02701-3
|
| 75 |
建伟 乔. A Study on the Correlation between Postoperative Changes in Serum Carcinoembryonic Antigen (CEA) Levels and Prognosis in Patients with Stage II/III Colorectal Cancer after Surgery. Medical Diagnosis 2025; 15(03) doi: 10.12677/md.2025.153038
|
| 76 |
J R Burke, P Brown, A Quyn, H Lambie, D Tolan, P Sagar. Tumour growth rate of carcinoma of the colon and rectum: retrospective cohort study. BJS Open 2020; 4(6) doi: 10.1002/bjs5.50355
|
| 77 |
Vlad Alexandru Ionescu, Gina Gheorghe, Nicolae Bacalbasa, Alexandru Laurentiu Chiotoroiu, Camelia Diaconu. Colorectal Cancer: From Risk Factors to Oncogenesis. Medicina 2023; 59(9) doi: 10.3390/medicina59091646
|
| 78 |
Stefan Moritsch, Bernadette Mödl, Irene Scharf, Lukas Janker, Daniela Zwolanek, Gerald Timelthaler, Emilio Casanova, Maria Sibilia, Thomas Mohr, Lukas Kenner, Dietmar Herndler-Brandstetter, Christopher Gerner, Mathias Müller, Birgit Strobl, Robert Eferl. Tyk2 is a tumor suppressor in colorectal cancer. OncoImmunology 2022; 11(1) doi: 10.1080/2162402X.2022.2127271
|
| 79 |
Ramesh K. Wali, Laura Bianchi, Sonia Kupfer, Mart De La Cruz, Borko Jovanovic, Christopher Weber, Michael J. Goldberg, L. M. Rodriguez, Raymond Bergan, David Rubin, Mary Beth Tull, Ellen Richmond, Beth Parker, Seema Khan, Hemant K. Roy, John Green. Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial. PLOS ONE 2018; 13(4) doi: 10.1371/journal.pone.0193544
|
| 80 |
Pedro Pedrosa, M. Luísa Corvo, Margarida Ferreira-Silva, Pedro Martins, Manuela Colla Carvalheiro, Pedro M. Costa, Carla Martins, L. M. D. R. S. Martins, Pedro V. Baptista, Alexandra R. Fernandes. Targeting Cancer Resistance via Multifunctional Gold Nanoparticles. International Journal of Molecular Sciences 2019; 20(21) doi: 10.3390/ijms20215510
|
| 81 |
Christopher M. Stevens, Yaxian Zhou, Peng Teng, Lauren N. Rault, Yaxian Liao, Weiping Tang. Development of Oligomeric Mannose-6-phosphonate Conjugates for Targeted Protein Degradation. ACS Medicinal Chemistry Letters 2023; 14(6) doi: 10.1021/acsmedchemlett.2c00479
|
| 82 |
Jun Xiao, Yangkun Cao, Xuan Li, Long Xu, Zhihang Wang, Zhenyu Huang, Xuechen Mu, Yinwei Qu, Ying Xu. Elucidation of Factors Affecting the Age-Dependent Cancer Occurrence Rates. International Journal of Molecular Sciences 2024; 26(1) doi: 10.3390/ijms26010275
|
| 83 |
Leesha K. Gunnink, Ola D. Alabi, Benjamin D. Kuiper, Stephen M. Gunnink, Sam J. Schuiteman, Lauren E. Strohbehn, Kathryn E. Hamilton, Kathryn E. Wrobel, Larry L. Louters. Curcumin directly inhibits the transport activity of GLUT1. Biochimie 2016; 125 doi: 10.1016/j.biochi.2016.03.014
|
| 84 |
Yong Joon Cho, Gyu‐Jin Lee, Jong‐Ha Park, Sung In Lim. Orthogonal Tri‐Modular Coiled‐Coil Assembly for Programmable Multi‐Cargo Display on Escherichia coli Nissle 1917. Small 2026; 22(28) doi: 10.1002/smll.202512642
|
| 85 |
Alexandru Necula, Andrei Belu , Claudia Cristina Burz . The Predictive Role of Circulating Inflammatory Biomarkers in the Response to Cetuximab-Based Therapy for unresectable stage IV Metastatic Colorectal Cancer. Journal of Medical and Radiation Oncology 2024; 4(7) doi: 10.53011/JMRO.2024.01.03
|
| 86 |
Antonio Barbáchano, María Jesús Larriba, Gemma Ferrer-Mayorga, José Manuel González-Sancho, Alberto Muñoz. Vitamin D. 2018; doi: 10.1016/B978-0-12-809963-6.00099-7
|
| 87 |
Chao-Yuan Yu, Wei-Chiao Chang, Jia-Huei Zheng, Wei-Hung Hung, Er-Chieh Cho. Transforming growth factor alpha promotes tumorigenesis and regulates epithelial-mesenchymal transition modulation in colon cancer. Biochemical and Biophysical Research Communications 2018; 506(4) doi: 10.1016/j.bbrc.2018.10.137
|
| 88 |
Khalid Saad Alharbi. The ncRNA-TGF-β axis: Unveiling new frontiers in colorectal cancer research. Pathology - Research and Practice 2024; 254 doi: 10.1016/j.prp.2024.155138
|
| 89 |
Seung-Hee Cho, Byung-Joon Seung, Soo-Hyeon Kim, Min-Kyung Bae, Ha-Young Lim, Jung-Hyang Sur. EGFR Overexpression and Sequence Analysis of KRAS, BRAF, and EGFR Mutation Hot Spots in Canine Intestinal Adenocarcinoma. Veterinary Pathology 2021; 58(4) doi: 10.1177/03009858211009778
|
| 90 |
Ryan Timothy D. Yu, Reynaldo L. Garcia. NRAS mutant E132K identified in young-onset sporadic colorectal cancer and the canonical mutants G12D and Q61K affect distinct oncogenic phenotypes. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-67796-8
|
| 91 |
Dmitry Kamashev, Nina Shaban, Galina Zakharova, Alexander Modestov, Мargarita Kamynina, Sergey Baranov, Anton Buzdin. Lapatinib-induced enhancement of mitochondrial respiration in HER2-positive SK-BR-3 cells: mechanism revealed by analysis of proteomic but not transcriptomic data. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1470496
|
| 92 |
Cristina Pereira-Wilson. Can dietary flavonoids be useful in the personalized treatment of colorectal cancer?. World Journal of Gastrointestinal Oncology 2022; 14(6): 1115-1123 doi: 10.4251/wjgo.v14.i6.1115
|
| 93 |
Zhenhua Jin, Yin Li, Hao Yi, Menghui Wang, Chaofeng Wang, Shaokun Du, Wenjuan Zeng, Zhen Zong. Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review). International Journal of Oncology 2025; 66(3) doi: 10.3892/ijo.2025.5728
|
| 94 |
Nina Shaban, Dmitri Kamashev, Aleksandra Emelianova, Anton Buzdin. Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications. Cells 2023; 13(1) doi: 10.3390/cells13010047
|
| 95 |
Lifeng Zeng, Jinrong Qian, Xiaojiang Luo, Aiqun Zhou, Zhiyong Zhang, Quangang Fang. CHSY1 promoted proliferation and suppressed apoptosis in colorectal cancer through regulation of the NFκB and/or caspase‑3/7 signaling pathway. Oncology Letters 2018; doi: 10.3892/ol.2018.9385
|
| 96 |
F A Dain Md Opo, Mohammed Moulay, Ali Zari, Afnan Alqaderi, Saleh Alkarim, Talal Zari, Mohiuddin Ahmed Bhuiyan, Maged Mostafa Mahmoud, Fadwa Aljoud, Mohd Suhail, Sherif Edris, Wafaa S. Ramadan, Mohammad Amjad Kamal, Saïd Nemmiche, Foysal Ahammad. Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and in-vitro studies. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1027890
|
| 97 |
Wittaya Suwakulsiri, Rong Xu, Alin Rai, Maoshan Chen, Adnan Shafiq, David W. Greening, Richard J. Simpson. Transcriptomic analysis and fusion gene identifications of midbody remnants released from colorectal cancer cells reveals they are molecularly distinct from exosomes and microparticles. PROTEOMICS 2024; 24(11) doi: 10.1002/pmic.202300058
|
| 98 |
Roberto de Paula do Nascimento, Julia Soto Rizzato, Gabriele Polezi, Hatim Boughanem, Non Gwenllian Williams, Renata Galhardo Borguini, Manuela Cristina Pessanha de Araujo Santiago, Mario Roberto Marostica Junior, Lee Parry. Myrciaria jaboticaba Fruit Peel: Bioactive Composition as Determined by Distinct Harvest Seasons and In Vitro Anti-Cancer Activity. Plants 2024; 13(20) doi: 10.3390/plants13202907
|
| 99 |
Tzuriel Sapir, David Shifteh, Moshe Pahmer, Sanjay Goel, Radhashree Maitra. Protein Arginine Methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K Pathways: A Case for PRMT5 Inhibition and Combination Therapies in Cancer. Molecular Cancer Research 2021; 19(3) doi: 10.1158/1541-7786.MCR-20-0745
|
| 100 |
Ashkan Hajjafari, Soheil Sadr, Abbas Rahdar, Mansour Bayat, Narges Lotfalizadeh, Shiva Dianaty, Arezou Rezaei, Soroush Partovi Moghaddam, Khashayar Hajjafari, Pouria Ahmadi Simab, Zelal Kharaba, Hassan Borji, Sadanand Pandey. Exploring the integration of nanotechnology in the development and application of biosensors for enhanced detection and monitoring of colorectal cancer. Inorganic Chemistry Communications 2024; 164 doi: 10.1016/j.inoche.2024.112409
|
| 101 |
Thinzar M. Lwin, Michael A. Turner, Siamak Amirfakhri, Hiroto Nishino, Robert M. Hoffman, Michael Bouvet. Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible. Cells 2022; 11(2) doi: 10.3390/cells11020249
|
| 102 |
Abeer A.A. Salama, Rasha M. Allam. Promising targets of chrysin and daidzein in colorectal cancer: Amphiregulin, CXCL1, and MMP-9. European Journal of Pharmacology 2021; 892 doi: 10.1016/j.ejphar.2020.173763
|
| 103 |
Yaxian Zhou, Peng Teng, Nathan T. Montgomery, Xiaolei Li, Weiping Tang. Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins. ACS Central Science 2021; 7(3) doi: 10.1021/acscentsci.1c00146
|
| 104 |
Gemma Ferrer-Mayorga, Alberto Muñoz, José Manuel González-Sancho. Feldman and Pike's Vitamin D. 2024; doi: 10.1016/B978-0-323-91338-6.00039-2
|
| 105 |
Anastasia Goloudina, Fabien Le Chevalier, Pierre Authié, Pierre Charneau, Laleh Majlessi. Shared neoantigens for cancer immunotherapy. Molecular Therapy Oncology 2025; 33(2) doi: 10.1016/j.omton.2025.200978
|
| 106 |
Qiong Wang, Yiqun Chen, Jaeyoung Park, Xiao Liu, Yifeng Hu, Tiexin Wang, Kevin McFarland, Michael J. Betenbaugh. Design and Production of Bispecific Antibodies. Antibodies 2019; 8(3) doi: 10.3390/antib8030043
|
| 107 |
Sonal M. Manohar, Kalpana S. Joshi. Molecular pharmacology of multitarget cyclin-dependent kinase inhibitors in human colorectal carcinoma cells. Expert Opinion on Therapeutic Targets 2023; 27(3) doi: 10.1080/14728222.2023.2199924
|
| 108 |
Yalei Zhao, Xiaoyun Zhang, Yabin Liu, Yiping Ma, Pong Kong, Tianliang Bai, Mei Han, Binghui Li. Inhibition of ALAS1 activity exerts anti-tumour effects on colorectal cancer in vitro. Saudi Journal of Gastroenterology 2020; 26(3) doi: 10.4103/sjg.SJG_477_19
|
| 109 |
Philip E. Dubé, Cambrian Y. Liu, Nandini Girish, M. Kay Washington, D. Brent Polk. Pharmacological activation of epidermal growth factor receptor signaling inhibits colitis-associated cancer in mice. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-27353-w
|
| 110 |
Winnie Fong, Kenneth K. W. To. Drug repurposing to overcome resistance to various therapies for colorectal cancer. Cellular and Molecular Life Sciences 2019; 76(17) doi: 10.1007/s00018-019-03134-0
|